SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-179284
Filing Date
2021-06-02
Accepted
2021-06-02 07:51:32
Documents
15
Period of Report
2021-06-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d131786d8k.htm   iXBRL 8-K 25193
2 EX-99.1 d131786dex991.htm EX-99.1 42749
6 GRAPHIC g131786gra006.jpg GRAPHIC 5938
7 GRAPHIC g131786gra008.jpg GRAPHIC 1593
  Complete submission text file 0001193125-21-179284.txt   209620

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rprx-20210602.xsd EX-101.SCH 3071
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rprx-20210602_lab.xml EX-101.LAB 17372
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rprx-20210602_pre.xml EX-101.PRE 10953
8 EXTRACTED XBRL INSTANCE DOCUMENT d131786d8k_htm.xml XML 3456
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39329 | Film No.: 21987689
SIC: 2834 Pharmaceutical Preparations